UCSF Secures $824M From NIH, Topping All Public Universities
March 11, 2026 · 2 min read
David Almeida
UC San Francisco pulled in $824 million from the National Institutes of Health in fiscal year 2025, cementing its position as the nation's top public recipient of NIH funding for the fourteenth consecutive year.
The university's annual NIH report, released this week, ranks UCSF second overall behind only Johns Hopkins — and first among all public institutions by a wide margin. The university's four professional schools each dominated their peers: Medicine, Pharmacy, and Dentistry ranked first nationally, while Nursing placed first among public institutions and fourth overall.
What $824 Million Buys
The awards fund research spanning cancer, neurological disorders, infectious disease, and precision medicine across hundreds of labs. But the impact extends well beyond San Francisco. UCSF researchers collaborate with institutions in all 50 states, and the economic multiplier is substantial: a United for Medical Research analysis found that every dollar of NIH funding generates $2.56 in local economic activity.
In California alone, the biotech sector employs 150,491 people directly and supports another 254,365 jobs indirectly, generating $123.6 billion for the state economy according to Biocom California.
Lessons for Institutions Chasing NIH Dollars
UCSF's sustained dominance offers a blueprint for research institutions navigating an uncertain federal funding climate. The university's strategy rests on three pillars: deep investment in translational research that connects bench science to patient outcomes, aggressive multi-PI and cross-departmental collaboration, and a robust grants infrastructure that supports faculty from concept through submission.
The timing of this report matters. Congress recently preserved NIH's budget at $48.7 billion for FY2026, rejecting the administration's proposed 40% cut. But flat funding against rising costs still means fewer awards in real terms — making the competition for NIH dollars fiercer than ever.
For academic researchers studying how top institutions structure their NIH portfolios, UCSF's approach to cross-school collaboration and translational focus offers actionable strategy. Tools like Granted can help research teams identify relevant NIH funding opportunities and build competitive proposals before deadlines arrive. Deeper analysis of institutional NIH strategy is available on the Granted blog.